Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a median lifespan of 2–3 years after diagnosis. There are few meaningful treatments that alter progression in this disease. Preclinical and clinical studies have demonstrated that neuroinflammation may play a key role in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafson, Michael P., Staff, Nathan P., Bornschlegl, Svetlana, Butler, Greg W., Maas, Mary L., Kazamel, Mohamed, Zubair, Adeel, Gastineau, Dennis A., Windebank, Anthony J., Dietz, Allan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526569/
https://www.ncbi.nlm.nih.gov/pubmed/28742871
http://dx.doi.org/10.1371/journal.pone.0182002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526569/
https://www.ncbi.nlm.nih.gov/pubmed/28742871
http://dx.doi.org/10.1371/journal.pone.0182002

Ejemplares similares